Skip to content

Author

Khalid Mohammed Naji

We have 2 of 32 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Selenium attenuates tolfenpyrad-induced immunotoxicity in the spleen and Peyer’s patches of albino rats

Tolfenpyrad (TPD) is a pyrazole insecticide that acts primarily by inhibiting mitochondrial respiratory chain complex I, potentially resulting in oxidative stress and cellular energy depletion. Its increasing agricultural use has raised concerns regarding possible immunotoxic effects in non-target organisms. Selenium (...

Bushra Y. H. Al-Khatib, Elham A. S. Al-Shaibani, Nada M. H. Al-Hamdani et al. · 0 citations
Open access Jul 2026

Association between the PNPLA3 I148M (rs738409) polymorphism and risk of metabolic dysfunction-associated steatotic liver disease: a meta-analysis (2015-2025).

This updated meta-analysis confirms that the PNPLA3 rs738409 (I148M) polymorphism is a major genetic susceptibility factor for MASLD across diverse populations and supports the incorporation of PNPLA3 into multifactorial risk assessment models.

Muteia'a Hamood, M. A. Al-Salehi, A. Hussein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.